Language

English

Publication Date

4-25-2024

Journal

Blood

DOI

10.1182/blood.2023021174

PMID

38364184

PMCID

PMC11103099

PubMedCentral® Posted Date

2-18-2024

PubMedCentral® Full Text Version

Post-print

Abstract

Over the past 10 years, there has been a marked increase in recognition of the interplay between the intestinal microbiome and the hematopoietic system. Despite their apparent distance in the body, a large literature now supports the relevance of the normal intestinal microbiota to steady-state blood production, affecting both hematopoietic stem and progenitor cells as well as differentiated immune cells. Microbial metabolites enter the circulation where they can trigger cytokine signaling that influences hematopoiesis. Furthermore, the state of the microbiome is now recognized to affect outcomes from hematopoietic stem cell transplant, immunotherapy, and cellular therapies for hematologic malignancies. Here we review the mechanisms by which microbiotas influence hematopoiesis in development and adulthood as well as the avenues by which microbiotas are thought to impact stem cell transplant engraftment, graft-versus-host disease, and efficacy of cell and immunotherapies. We highlight areas of future research that may lead to reduced adverse effects of antibiotic use and improved outcomes for patients with hematologic conditions.

Keywords

Humans, Gastrointestinal Microbiome, Hematopoiesis, Hematologic Diseases, Animals, Hematopoietic Stem Cell Transplantation, Graft vs Host Disease

Published Open-Access

yes

BLOOD_BLD-2023-021174-C-ga1.jpg (405 kB)
Graphical Abstract

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.